Turkmenistan registers Russia's Sputnik V vaccine, says RDIF

  • The vaccine was approved under the emergency use authorisation procedure without additional clinical trials in Turkmenistan.
18 Jan, 2021

MOSCOW: Turkmenistan became the first country in Central Asia to register Russia's Sputnik V vaccine against COVID-19, the Russian Direct Investment Fund (RDIF) said on Monday.

"The vaccine was approved under the emergency use authorisation procedure without additional clinical trials in Turkmenistan," the RDIF said in a statement.

Read Comments